| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |